Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma

The most common malignant central nervous system tumor is glioblastoma multiforme (GBM). Cytokine-induced killer (CIK) cell therapy is a promising type of adoptive cell immunotherapy for various cancers. We previously conducted a randomized clinical trial on CIK cell therapy in patients with GBM. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Myung-Hoon, Kim, Jae Min, Cheong, Jin Hwan, Ryu, Je Il, Won, Yu Deok, Nam, Gun He, Kim, Choong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033287/
https://www.ncbi.nlm.nih.gov/pubmed/35463313
http://dx.doi.org/10.3389/fonc.2022.851628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033287/
https://www.ncbi.nlm.nih.gov/pubmed/35463313
http://dx.doi.org/10.3389/fonc.2022.851628

Ejemplares similares